Cargando…
Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
Sustained virological response (SVR) rates have increased remarkably since the introduction of direct-acting antiviral agents (DAAs) for chronic hepatitis C. Autotaxin (ATX) is a secreted enzyme converting lysophosphatidylcholine to lysophosphatidic acid and a newly established biomarker for liver f...
Autores principales: | Yamazaki, Tomoo, Joshita, Satoru, Umemura, Takeji, Usami, Yoko, Sugiura, Ayumi, Fujimori, Naoyuki, Kimura, Takefumi, Matsumoto, Akihiro, Igarashi, Koji, Ota, Masao, Tanaka, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884565/ https://www.ncbi.nlm.nih.gov/pubmed/29617443 http://dx.doi.org/10.1371/journal.pone.0195632 |
Ejemplares similares
-
Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2018) -
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018) -
Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2017) -
Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
por: Joshita, Satoru, et al.
Publicado: (2019) -
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
por: Kimura, Takefumi, et al.
Publicado: (2018)